CURRENT OPINION IN NEUROLOGY is a premier academic journal dedicated to providing insightful overviews and critical analyses across all areas of neurology and clinical neurology. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an impressive impact factor, highlighting its influence and relevance in the field—positioning it in the Q1 category for both neurology and clinical neurology as of 2023. With its comprehensive coverage, the journal serves as a vital resource for researchers, healthcare professionals, and students aiming to stay abreast of the latest developments, trends, and breakthroughs in neurological science and practice. Though not open access, articles are available via institutional subscriptions or individual purchase, ensuring that vital research remains accessible to a wide audience. Covering research from its inception in 1993 to ongoing studies in 2024, CURRENT OPINION IN NEUROLOGY stands out as an essential platform for disseminating knowledge and fostering dialogue within the dynamic and evolving landscape of neurology.

Welcome to the JOURNAL OF VASCULAR RESEARCH, a reputable academic journal published by KARGER that has been a cornerstone of vascular research since 1964. With an ISSN of 1018-1172 and an E-ISSN of 1423-0135, this journal plays a vital role in disseminating cutting-edge research in the fields of Cardiology and Cardiovascular Medicine and Physiology. Currently categorized in the Q3 quartile for both disciplines, it ranks as #179 in Cardiology and #131 in Physiology according to Scopus, showcasing its significant contribution to the scientific community. Although the journal operates on a subscription basis, it strives to provide accessible content that informs and inspires researchers, professionals, and students alike. As the journal looks forward to its convergence in 2024, it continues to uphold its mission of advancing knowledge, fostering innovation, and encouraging collaboration within the dynamic realm of vascular research.

AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, published by Elsevier, stands as a pivotal journal in the fields of Cellular and Molecular Neuroscience, Endocrine and Autonomic Systems, and Neurology (Clinical), boasting an impressive Q2 ranking in the latter two categories as of 2023. This journal, which has been in circulation since 2000, provides a vital platform for disseminating innovative research pertaining to the autonomic nervous system's fundamental and clinical aspects, thus addressing significant challenges in both theoretical understanding and clinical application. Researchers and practitioners worldwide find value in its comprehensive articles, reviews, and case studies that explore the intricacies of autonomic neurobiology. As part of Elsevier's prestigious portfolio, the journal offers options for Open Access, enhancing the visibility and accessibility of its content. With an increasing impact on clinical practices and research directions, AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL serves as an essential resource for advancing knowledge and fostering collaboration among scholars, clinicians, and students dedicated to unraveling the complexities of the autonomic nervous system.

The Journal of Electromyography and Kinesiology, published by Elsevier, is a distinguished academic platform that focuses on the intricate interrelations between electromyography, kinetic analysis, and their applications in health and sports sciences. Established in 1991, this journal has maintained a rigorous publication standard and continues to be pivotal in advancing knowledge in biophysics, neurology, and sports science, with impressive Q1 and Q2 ratings in multiple categories as of 2023. With an impact factor that underscores its significance in the scientific community, the journal contributes to a deeper understanding of muscle function and movement patterns, making it an essential resource for researchers, healthcare professionals, and students alike. While it operates under a subscription model, the insights provided by the journal are invaluable for anyone invested in the fields of biomechanics, rehabilitation, and neuromuscular research. For over three decades, this journal has become a cornerstone for disseminating groundbreaking research and fostering collaboration among scholars in the ever-evolving landscape of kinesiology and electromyography.

Neurology Research International, published by HINDAWI LTD, is an esteemed open access journal that has been serving the neurology community since 2010. With its ISSN 2090-1852 and E-ISSN 2090-1860, this journal aims to foster knowledge dissemination and facilitate dialogue surrounding key issues in neurology and clinical neuroscience, making it a vital resource for researchers, clinicians, and students alike. It operates from the United States, with its administrative hub located in London, England. As of 2023, the journal has been positioned in the Q3 category for both neurology and clinical neurology, reflecting its commitment to advancing research within these critical fields. With a current Scopus rank of #216/400 in clinical neurology and a #113/192 in neuroscience, and a converged publication timeline from 2010 to 2024, Neurology Research International is dedicated to promoting high-quality research that addresses contemporary challenges and innovations in neurological science. By offering open access since its inception, it ensures that cutting-edge research is freely available, aligning with the global push towards accessible scientific communication.

JOURNAL OF GENERAL PHYSIOLOGY, published by Rockefeller University Press, is a leading peer-reviewed journal that has been at the forefront of physiological research since its inception in 1918. With an ISSN of 0022-1295 and an E-ISSN of 1540-7748, this esteemed journal maintains an impressive Q1 ranking in the field of Physiology, reflecting its high-quality contributions to both the basic and applied aspects of physiology. Regularly cited in the scientific community, it ranks 70th out of 193 in the category of Biochemistry, Genetics, and Molecular Biology, showcasing its significant impact within academic circles. The journal publishes original research, reviews, and commentaries, aiming to advance the understanding of physiological mechanisms and their implications across various biological systems. Although not Open Access, the journal remains a vital resource for researchers, professionals, and students dedicated to exploring the depths of cardiopulmonary function, neurophysiology, and cellular biochemical processes. The JOURNAL OF GENERAL PHYSIOLOGY continues to serve as a critical platform for disseminating innovative findings and fostering collaboration among scientists globally.

NEUROMUSCULAR DISORDERS is a premier academic journal published by PERGAMON-ELSEVIER SCIENCE LTD, focusing on the latest research and developments in the fields of neurology, genetics, and pediatric health. With an ISSN of 0960-8966 and an E-ISSN of 1873-2364, this journal has established a significant presence since its inception in 1991, and it continues to contribute to the scientific community with its impactful findings and reviews. The journal boasts a commendable impact factor, reflected in its placement in the Q2 category for Clinical Genetics and Neurology, as well as its positioning in the top tier Q1 for Pediatrics, Perinatology and Child Health according to the latest quartile assessments. With Scopus rankings such as Rank #71/330 in Pediatrics and Rank #51/99 in Clinical Genetics, NEUROMUSCULAR DISORDERS is recognized for its contribution to advancing knowledge in neuromuscular diseases. The journal is essential for researchers, clinicians, and students interested in the intricate relationship between genetics and neurological disorders, providing valuable insights that drive innovation and improve patient care.

JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, published by Springer in the Netherlands, serves as a pivotal platform for disseminating high-quality research within the fields of physiology, biochemistry, and related biomedical sciences. With an impressive impact factor reflected in its categorization as Q2 in Biochemistry and Q1 in Medicine (miscellaneous), this journal fosters a vibrant community of scholars dedicated to advancing knowledge and innovation. The journal’s broad scope encompasses a wide range of topics from cellular mechanisms to systemic physiology, making it relevant for both theoretical and applied sciences. Researchers and practitioners are encouraged to utilize the available Open Access options to reach a wider audience. The journal’s continuous contribution to the scientific dialogue since its inception in 1996 positions it as a key resource for professionals and students alike, facilitating the exploration of cutting-edge topics and collaborative research opportunities.

Clinical Physiology and Functional Imaging, published by Wiley, is a distinguished journal dedicated to advancing the fields of clinical physiology and biomedical imaging. This UK-based publication, with an ISSN of 1475-0961 and an E-ISSN of 1475-097X, has established itself as an important resource for researchers and professionals from various backgrounds, focusing on the physiological mechanisms underlying human health and disease through innovative imaging techniques. With a convergence year span from 2002 to 2024, the journal is classified within the Q3 quartile across several medical and physiology categories in 2023, reflecting its commitment to quality research amid a competitive landscape. Although it currently lacks an H-index, its rankings within Scopus—#70 in Medicine (Miscellaneous) and #134 in Biochemistry, Genetics and Molecular Biology—underscore its relevance in a rapidly evolving field. Engaging with this journal offers an opportunity to explore emerging research that bridges clinical practice and advanced imaging modalities, making it an essential read for students and established professionals alike.

Therapeutic Advances in Neurological Disorders, published by SAGE Publications Ltd, is a leading open access journal dedicated to the advancement of knowledge in the field of neurology. Since its inception in 2008, this journal has established itself as a vital resource for researchers, healthcare professionals, and students, offering a platform for the dissemination of high-quality research that improves the understanding and treatment of neurological disorders. With a commendable impact factor and ranked Q1 in multiple categories, including Neurology and Pharmacology for 2023, it exemplifies excellence in scholarly contributions. The journal's Scope encompasses a wide array of topics, providing insights that are pivotal for clinical practice and pharmacological development. Additionally, with its commitment to open access since 2017, Therapeutic Advances in Neurological Disorders ensures that its research reaches a global audience, fostering collaboration and innovation in neurological science.